Catalyst Wire Dossier Catalyst Wire Dossier

Zolpidem Hemitartarate Orodispersible Tablet 1.75 mg

zolpidem hemitartarate · Biolab Sanus Farmaceutica
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zolpidem Hemitartarate Orodispersible Tablet 1.75 mg, covering 2018-06-08 to 2018-06-08. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 1.75 mg Formulation [Phase 1]

See pricing